UNSPSC 51142543: Apomorphine hydrochloride

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula 2C17H17NO2.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F39049Y068, chemically known as 6a.beta.-noraporphine-10,11-diol, 6-methyl-, hydrochloride but more generally known as apomorphine hydrochloride, which bears US NIH Compound Identifier 2215. European Medicines Agency schedules Apomorphine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12924MIG.

UNSPSC 51142543 Apomorphine hydrochloride is a Commodity code that in practice covers pharmaceutical products for emergency medical response and community health support. State and local governments procure these medications and related drug-management systems to support public health initiatives, substance-abuse interventions, and emergency medical services. The issuing bodies under this code include county health departments and community health agencies that operate as part of broader county government procurement structures.

Seminole County, Florida represents recent activity under the code, having issued IFB 60459723LAS in June 2026 to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023. The county required quarterly deliveries to the Seminole County Community Health Building in Sanford, electronic bid submission, unit pricing for each line item, drug-free workplace certification, E-Verify compliance, and standard commercial insurance. The contract was structured with an initial two-year term and one-year renewal option, a three-month probationary termination-at-will period, and potential FEMA funding with associated federal compliance obligations. The available recent-opportunity data does not show a broad geographic distribution or multiple issuing bodies under this code.